Applied DNA Sciences Inc
APDN5.620USD
0.000
Handelsschluss 11/04, 16:00（ET）Kurse um 15 Minuten verzögert
5.07MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Applied DNA Sciences Inc Unternehmen
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Applied DNA Sciences Inc Informationen
BörsenkürzelAPDN
Name des UnternehmensApplied DNA Sciences Inc
IPO-datumAug 24, 2001
CEOMs. Judith Murrah
Anzahl der mitarbeiter46
WertpapierartOrdinary Share
GeschäftsjahresendeAug 24
Addresse50 Health Sciences Drive
StadtSTONY BROOK
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl11790
Telefon16312408800
Websitehttps://adnas.com/
BörsenkürzelAPDN
IPO-datumAug 24, 2001
CEOMs. Judith Murrah
Führungskräfte von Applied DNA Sciences Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
18.70K
+467275.00%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
18.69K
+623033.33%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
1.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Chairman of the Board
Chairman of the Board
1.00
-66.67%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
1.00
--
Ms. Elizabeth M. Schmalz Shaheen
Ms. Elizabeth M. Schmalz Shaheen
Independent Director
Independent Director
--
--
Mr. Sanjay M. Hurry
Mr. Sanjay M. Hurry
Executive Director - Investor Relations and Corporate Communications
Executive Director - Investor Relations and Corporate Communications
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
18.70K
+467275.00%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
18.69K
+623033.33%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
1.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Chairman of the Board
Chairman of the Board
1.00
-66.67%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
1.00
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product and authentication services - Large scale DNA production
161.00K
52.89%
Product and authentication services - Supply chain
91.32K
30.00%
Research and development services
52.07K
17.11%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Product and authentication services - Large scale DNA production
161.00K
52.89%
Product and authentication services - Supply chain
91.32K
30.00%
Research and development services
52.07K
17.11%
Aktionärsstatistik
Aktualisiert: Mon, Nov 3
Aktualisiert: Mon, Nov 3
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Anson Funds Management LP.
0.79%
Sabby Management, LLC
0.41%
Jantzen (Beth M)
0.32%
Shorrock (Clay)
0.32%
UBS Financial Services, Inc.
0.19%
Andere
97.98%
Aktionäre
Aktionäre
Anteil
Anson Funds Management LP.
0.79%
Sabby Management, LLC
0.41%
Jantzen (Beth M)
0.32%
Shorrock (Clay)
0.32%
UBS Financial Services, Inc.
0.19%
Andere
97.98%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
0.79%
Individual Investor
0.63%
Investment Advisor/Hedge Fund
0.41%
Investment Advisor
0.19%
Corporation
0.16%
Andere
97.82%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
59
89.41K
1.51%
+65.56K
2025Q2
62
34.98K
6.73%
-8.84K
2025Q1
84
45.20K
34.86%
+11.50K
2024Q4
79
25.60M
46.39%
+1.44M
2024Q3
74
1.08M
9.78%
+703.30K
2024Q2
73
1.19M
10.83%
+424.27K
2024Q1
67
243.32K
209.10%
+86.27K
2023Q4
64
96.98K
13.46%
-84.74K
2023Q3
66
149.12K
21.28%
-82.31K
2023Q2
68
142.47K
21.43%
-74.27K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Anson Funds Management LP.
46.51K
3.6%
+41.94K
+918.33%
Jun 30, 2025
Sabby Management, LLC
24.36K
1.89%
+17.39K
+249.63%
Jun 30, 2025
Jantzen (Beth M)
3.00
0%
--
--
Apr 03, 2025
Shorrock (Clay)
4.00
0%
--
--
Apr 03, 2025
UBS Financial Services, Inc.
11.13K
0.86%
+8.82K
+381.65%
Jun 30, 2025
UBS Switzerland AG
493.00
0.04%
+493.00
--
Jun 30, 2025
Tower Research Capital LLC
222.00
0.02%
+190.00
+593.75%
Jun 30, 2025
SBI Securities Co., Ltd.
146.00
0.01%
+79.00
+117.91%
Jun 30, 2025
Grossman (Bruce)
111.00
0.01%
+111.00
--
Feb 02, 2024
Sanctuary Advisors, LLC
20.00
0%
+20.00
--
Dec 31, 2024
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Datum
Art
Verhältnis
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
